-
平臺(tái)編號(hào)：bio-50845
-
國(guó)際編號(hào)：ATCC VR-786
-
拉丁屬名： Influenza B virus
-
規(guī)格：frozen
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
Influenza B virus
ATCC? Number:VR-786?
Classification: Orthomyxoviridae, Influenzavirus B
Agent: Influenza B virus
Strain: B/Brigit
Original Source: human case of influenza type B/Russia/69
Depositors: R.I.T. - Recherche et Industrie Therapeutiques
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : 8 to 11 day chicken embryo, i.a. inoculation chicken embryo
Incubation : Temperature: 37.0°C Duration: 1-4 days
Effect : Yes, in vitro effects: hemagglutination activity at 4C
References : 3475: et al., Peetermans J. Live influenza type B virus vaccines and preparation thereof. US Patent 3,962,423 dated Jun 8 1976
Classification: Orthomyxoviridae, Influenzavirus B
Agent: Influenza B virus
Strain: B/Brigit
Original Source: human case of influenza type B/Russia/69
Depositors: R.I.T. - Recherche et Industrie Therapeutiques
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : 8 to 11 day chicken embryo, i.a. inoculation chicken embryo
Incubation : Temperature: 37.0°C Duration: 1-4 days
Effect : Yes, in vitro effects: hemagglutination activity at 4C
References : 3475: et al., Peetermans J. Live influenza type B virus vaccines and preparation thereof. US Patent 3,962,423 dated Jun 8 1976
